Old gout drug may keep heart beating steady after valve surgery
NCT ID NCT04870424
First seen Jun 05, 2026 · Last updated Jun 19, 2026 · Updated 3 times
Summary
This study tested whether colchicine, a common gout medication, can prevent new atrial fibrillation and the need for a permanent pacemaker in people undergoing a minimally invasive aortic valve replacement (TAVI). About 200 patients with severe aortic stenosis took either colchicine or a placebo for 30 days after the procedure. The goal was to see if the drug's anti-inflammatory effects could reduce these common complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Inselspital, Bern University Hospital, Department of Cardiology
Bern, 3010, Switzerland
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.